Imbed Biosciences Announces FDA IDE Approval for Silver-Gallium Synthetic Antimicrobial Matrix Clinical Study with Human Donor Site Wounds

Imbed Biosciences announced the US FDA has approved an Investigational Device Exemption application to conduct a feasibility clinical trial to validate the safety of their pipeline polymeric matrix with silver and gallium ions in human donor site wounds.